{"title":"针对癌症的自然杀伤细胞","authors":"E. Hofer, U. Köhl","doi":"10.56181/llas2108","DOIUrl":null,"url":null,"abstract":"Natural killer cells have the ability to kill tumour cells, now researchers are looking to harness their potential as a means of treating different forms of cancer. The Mature NK project provides training to early stage researchers, helping them develop the skills that could lead to the development of more effective anti-cancer immunotherapies in future, as Dr Erhard Hofer explains on behalf of Dr. Ulrike Köhl, the coordinator of the project.","PeriodicalId":111577,"journal":{"name":"EU Research - The necessity of science in uncertain times","volume":"2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Natural killer cells to target cancer\",\"authors\":\"E. Hofer, U. Köhl\",\"doi\":\"10.56181/llas2108\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Natural killer cells have the ability to kill tumour cells, now researchers are looking to harness their potential as a means of treating different forms of cancer. The Mature NK project provides training to early stage researchers, helping them develop the skills that could lead to the development of more effective anti-cancer immunotherapies in future, as Dr Erhard Hofer explains on behalf of Dr. Ulrike Köhl, the coordinator of the project.\",\"PeriodicalId\":111577,\"journal\":{\"name\":\"EU Research - The necessity of science in uncertain times\",\"volume\":\"2 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1900-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"EU Research - The necessity of science in uncertain times\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.56181/llas2108\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"EU Research - The necessity of science in uncertain times","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56181/llas2108","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Natural killer cells have the ability to kill tumour cells, now researchers are looking to harness their potential as a means of treating different forms of cancer. The Mature NK project provides training to early stage researchers, helping them develop the skills that could lead to the development of more effective anti-cancer immunotherapies in future, as Dr Erhard Hofer explains on behalf of Dr. Ulrike Köhl, the coordinator of the project.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
